BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28913840)

  • 1. Loss of regulatory characteristics in CD4
    Bian LQ; Mao L; Bi Y; Zhou SW; Chen ZD; Wen J; Shi J; Wang L
    APMIS; 2017 Dec; 125(12):1108-1116. PubMed ID: 28913840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased suppression of CD8
    Giri PS; Dwivedi M; Begum R
    Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of human bone marrow mesenchymal stem cells on allogeneic regulatory T cells and its possible mechanism].
    Yang J; Wang QH; Zeng QT; Mao XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):785-9. PubMed ID: 17708804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of CD4(+) CD25(+) and CD25(-) T-Bet, GATA-3, Foxp3 and RORγt cells in allergic inflammation, local lung distribution and chemokine gene expression.
    Lu Y; Malmhäll C; Sjöstrand M; Rådinger M; O'Neil SE; Lötvall J; Bossios A
    PLoS One; 2011; 6(5):e19889. PubMed ID: 21625544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4
    Wei Y; Yu K; Wei H; Su X; Zhu R; Shi H; Sun H; Luo Q; Xu W; Xiao J; Zhong Y; Zeng Q
    Immunology; 2017 Jul; 151(3):291-303. PubMed ID: 28207945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Th17 and CD4+ CD25+ T regulatory cells in peripheral blood of acute leukemia patients and their prognostic significance.
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):619-624. PubMed ID: 28650331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.
    Zhou L; Cao T; Wang Y; Yao H; Du G; Chen G; Niu X; Tang G
    Inflammation; 2016 Jun; 39(3):1205-15. PubMed ID: 27106476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
    Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
    Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity.
    Stroopinsky D; Avivi I; Rowe JM; Avigan D; Katz T
    Eur J Immunol; 2009 Oct; 39(10):2703-15. PubMed ID: 19634189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
    Xu L; Kitani A; Fuss I; Strober W
    J Immunol; 2007 Jun; 178(11):6725-9. PubMed ID: 17513718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression.
    Ren CF; Zhao YX; Hou CF; Luan L; Duan GQ; Li SJ; Zhao JH
    Mol Med Rep; 2017 Jan; 15(1):460-466. PubMed ID: 27909722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD4+CD25+Foxp3+ Regulatory T Cells, Interleukin 10 and Transforming Growth Factor β in Newly Diagnosed Type 2 Diabetic Patients.
    Yuan N; Zhang HF; Wei Q; Wang P; Guo WY
    Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):96-101. PubMed ID: 28954308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.